Page 26 - Read Online

53. Kuo PL, Chiang LC, Lin CC. Resveratrol-induced apoptosis is mediated 70. Sharma A, Upadhyay AK, Bhat MK. Inhibition of Hsp27 and Hsp40
by p53-dependent pathway in Hep G2 cells. Life Sci 2002;72:23-34. potentiates 5-fl uorouracil and carboplatin mediated cell killing in
54. De Ledinghen V, Monvoisin A, Neaud V, Krisa S, Payrastre B, Bedin C, hepatoma cells. Cancer Biol Ther 2009;8:2106-13.
Desmoulière A, Bioulac-Sage P, Rosenbaum J. Trans-resveratrol, a 71. He W, Li LX, Liao QJ, Liu CL, Chen XL. Epigallocatechin gallate
grapevine-derived polyphenol, blocks hepatocyte growth factor-induced inhibits HBV DNA synthesis in a viral replication – Inducible cell line.
invasion of hepatocellular carcinoma cells. Int J Oncol 2001;19:83-8. World J Gastroenterol 2011;17:1507-14.
55. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD. Resveratrol 72. Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC.
inhibits hypoxia-induced accumulation of hypoxia-inducible San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus
factor-1alpha and VEGF expression in human tongue squamous cell replication and virus-induced cyclooxygenase-2 expression. J Viral
carcinoma and hepatoma cells. Mol Cancer Ther 2005;4:1465-74. Hepat 2011;18:e315-24.
56. Kocsis Z, Marcsek ZL, Jakab MG, Szende B, Tompa A. Chemopreventive 73. Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J. Total
properties of trans-resveratrol against the cytotoxicity of chloroacetanilide alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma
herbicides in vitro. Int J Hyg Environ Health 2005;208:211-8. growth in vivo and in vitro via activation of mitochondrial-dependent
57. Sun Z, Pan C, Liu H, Wang G. Anti-hepatoma activity of resveratrol apoptosis. Int J Oncol 2013;42:971-8.
in vitro. World J Gastroenterol 2002;8:79-81. 74. Hong Z, Chen W, Zhao J, Wu Z, Zhou J, Li T, Hu J. Hepatoprotective
58. Notas G, Nifl i AP, Kampa M, Vercauteren J, Kouroumalis E, Castanas E. effects of Rubus aleaefolius Poir and identification of its active
Resveratrol exerts its anti-proliferative effect on HepG2 hepatocellular constituents. J Ethnopharmacol 2010;129:267-72.
carcinoma cells, by inducing cell cycle arrest, and NOS activation. 75. Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, Xu Y,
Biochim Biophys Acta 2006;1760:1657-66. Stoner GD, Klaunig JE. Inhibition of cellular transformation by berry
59. Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W. Resveratrol inhibits extracts. Carcinogenesis 2001;22:351-6.
tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 76. Lee JH, Ham YA, Choi SH, Im EO, Jung JH, Im KS, Kim DK, Xu Y,
expression and invasion of human hepatocellular carcinoma cells. Wang MW, Kim ND. Activity of crude extract of Rubus crataegifolius
Biomed Pharmacother 2008;62:366-72. roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor.
60. Yerian LM, Anders RA, Tretiakova M, Hart J. Caveolin and Arch Pharm Res 2000;23:338-43.
thrombospondin expression during hepatocellular carcinogenesis. Am 77. Borner C. The Bcl-2 protein family: sensors and checkpoints for
J Surg Pathol 2004;28:357-64. life-or-death decisions. Mol Immunol 2003;39:615-47.
61. Yu L, Sun ZJ, Wu SL, Pan CE. Effect of resveratrol on cell cycle 78. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond
proteins in murine transplantable liver cancer. World J Gastroenterol respiration. Nat Rev Mol Cell Biol 2008;9:532-42.
2003;9:2341-3. 79. Zhao G, Dai S, Chen R. Dictionary of traditional Chinese medicine.
62. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Shanghai: Shanghai Scientific and Technical Publishers; 2006.
Leeuwen PA. Flavonoids: a review of probable mechanisms of action p. 2459-60.
and potential applications. Am J Clin Nutr 2001;74:418-25. 80. Bolhassani A, Khavari A, Bathaie SZ. Saffron and natural carotenoids:
63. Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, biochemical activities and anti-tumor effects. Biochim Biophys Acta
Panopoulos N. Biotechnology of flavonoids and other 2014;1845:20-30.
phenylpropanoid-derived natural products. Part I: chemical diversity, 81. Bakshi H, Sam S, Rozati R, Sultan P, Islam T, Rathore B, Lone Z,
impacts on plant biology and human health. Biotechnol J 2007;2:1214-34. Sharma M, Triphati J, Saxena RC. DNA fragmentation and cell cycle
64. Cui X, Wang Y, Kokudo N, Fang D, Tang W. Traditional Chinese arrest: a hallmark of apoptosis induced by crocin from Kashmiri
medicine and related active compounds against hepatitis B virus saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev
infection. Biosci Trends 2010;4:39-47. 2010;11:675-9.
65. Handoussa H, Osmanova N, Ayoub N, Mahran L. Spicatic acid: a 82. Bathaie SZ, Miri H, Mohagheghi MA, Mokhtari-Dizaji M,
4-carboxygentisic acid from Gentiana spicata extract with potential Shahbazfar AA, Hasanzadeh H. Saffron aqueous extract inhibits the
hepatoprotective activity. Drug Discov Ther 2009;3:278-86. chemically-induced gastric cancer progression in the wistar albino rat.
66. Abdel-Salam OM, Youness ER, Mohammed NA, Abd-Elmoniem M, Iran J Basic Med Sci 2013;16:27-38.
Omara E, Sleem AA. Neuroprotective and hepatoprotective 83. Sun Y, Xu HJ, Zhao YX, Wang LZ, Sun LR, Wang Z, Sun XF.
effects of micronized purified flavonoid fraction (Daflon(R)) in Crocin exhibits anti-tumor effects on human leukemia HL-60 cells
lipopolysaccharide-treated rats. Drug Discov Ther 2012;6:306-14. in vitro and in vivo. Evid Based Complement Alternat Med
67. Jiang CP, Ding H, Shi DH, Wang YR, Li EG, Wu JH. Pro-apoptotic 2013;2013:690164.
effects of tectorigenin on human hepatocellular carcinoma HepG2 cells. 84. Noureini SK, Wink M. Anti-proliferative effects of crocin in HepG2 cells
World J Gastroenterol 2012;18:1753-64. by telomerase inhibition and hTERT down-regulation. Asian Pac J
68. Dorn C, Kraus B, Motyl M, Weiss TS, Gehrig M, Scholmerich J, Cancer Prev 2012;13:2305-9.
Heilmann J, Hellerbrand C. Xanthohumol, a chalcon derived from 85. Li CY, Huang WF, Wang QL, Wang F, Cai E, Hu B, Du JC, Wang J,
hops, inhibits hepatic infl ammation and fi brosis. Mol Nutr Food Res Chen R, Cai XJ, Feng J, Li HH. Crocetin induces cytotoxicity in colon
2010;54:S205-13. cancer cells via p53-independent mechanisms. Asian Pac J Cancer Prev
69. Jin J, Chang Y, Wei W, He YF, Hu SS, Wang D, Wu YJ. Prostanoid 2012;13:3757-61.
EP1 receptor as the target of (-)-epigallocatechin-3-gallate in 86. Tseng TH, Chu CY, Huang JM, Shiow SJ, Wang CJ. Crocetin protects
suppressing hepatocellular carcinoma cells in vitro. Acta Pharmacol against oxidative damage in rat primary hepatocytes. Cancer Lett
Sin 2012;33:701-9. 1995;97:61-7.

124 Hepatoma Research | Volume 1 | Issue 3 | October 15, 2015